The introduction of troglitazone, a potent antidiabetic agent, marked a important chapter in the control of type 2 diabetes. However, its removal from the market due to serious hepatotoxicity spurred broad investigation into related thiazolidinediones. Later pioglitazone and rosiglitazone emerged, offering akin mechanisms of action – primarily i… Read More